A Phase 2A study of ALXN1007 in subjects with newly diag

Project: Research project

Project Details

Description

A Phase 2A study of ALXN1007 in subjects with newly diagnosed acute graft-versus-host disease involving the lower gastrointestinal tract
StatusFinished
Effective start/end date3/4/143/30/18

Funding

  • ALEXION PHARMACEUTICALS

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.